safety of retatrutide for Weight Loss: What It Is, How It Works & Side Effects Who Should Avoid Taking Retatrutide?

Notably, various exendin-4-based GLP-1RAs (Exenatide: 39 aa and Lixisenatide: 44 aa), and GLP-1-based GLP-1RAs (Dulaglutide: 31 aa, Liraglutide: 31 aa, Semaglutide: 31 aa, Tirzepatide: 39 aa, and Albiglutide: 60 aa) have been developed and approved by the FDA between 2005 and 2022 for the management of T2DM ( Interestingly, until now, primarily long-chain peptides with 3339 amino acids have been developed as GLP-1RAs, which also carry a cost burden

Int J Pancreatol 22: 23-29, 1997

But it cannot replace: consistent meal structure adequate protein intake fibre from whole foods micronutrient sufficiency stable blood sugar patterns reduced inflammatory food exposure Metabolism is built through daily behaviour

This article reflects information available in July 2026

The search strategy targeted studies involving GLP-1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, lixisenatide, benaglutide, loxenatide, semaglutide) and multi-target receptor agonists (e.g., tirzepatide), focusing on gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite) in patients with type 2 diabetes mellitus (T2DM) (Supplementary Material)

Its about: Preserving skin quality Maintaining muscle Supporting long-term metabolic health And approaching wellness as a whole system Final Thought GLP-1 is powerful